Showing results (21-30 of 7,586) with videos related to
Sort By:
Pageof 759
Peptides|January 22, 2003
Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic backgroundL Lin, J Wisor, T Shiba, et al.Progress in Neurobiology|May 1, 1997
Pharmacological aspects of human and canine narcolepsyS Nishino, E MignotJournal of Neurochemistry|April 1, 1985
Effects of rat ovariectomy on CSF monoamine metabolite levels and eliminationC Duval, E MignotArchives Italiennes De Biologie|October 21, 2004
Narcolepsy research: past, present, and future perspectivesS Fromherz, E MignotClinical Pharmacokinetics|December 20, 1999
Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerationsS Nishino, E MignotJournal of Neurochemistry|November 1, 1985
Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosineE Mignot, D LaudeBioessays : News and Reviews in Molecular, Cellular and Developmental Biology|May 8, 2001
Hypocretin/orexin, sleep and narcolepsyM Hungs, E MignotAmerican Journal of Human Genetics|February 17, 2001
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groupsE Mignot, L Lin, W Rogers, et al.Brain, Behavior, and Immunity|May 26, 2004
Exploring the cytokine and endocrine involvement in narcolepsyM L Okun, S Giese, L Lin, et al.Sleep|October 1, 1992
DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcolepticsE Mignot, X Lin, J Kalil, et al.Pageof 759